Trials / Completed
CompletedNCT01716819
Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity
Role of the Renin Angiotensin Aldosterone System and Remodeling of the Matrix Cardiac Extra Cellular in the Mechanisms of Transition to Heart Failure in Abdominal Obesity: Prospective Longitudinal Study R2C2 II
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 43 Years – 72 Years
- Healthy volunteers
- Accepted
Summary
R2C2 study has shown that abdominal obesity is associated with a cardiac and vascular remodelling in healthy volunteers. This remodelling is correlated with renin-angiotensin aldosterone system (RAAS) activation and/or systemic fibrosis. R2C2 II study is designed to confirm the hypothesis that RAAS is associated with an early remodelling and implicated in the transition to cardiac failure in abdominal obesity.
Detailed description
Follow up of abdominal obesity patients from the R2C2 cohort study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Urine sample | dosages on one spot and 24h collection |
| OTHER | Blood sample | dosages |
| OTHER | Assessment of sleep apnea syndrome | |
| OTHER | Electrocardiogram | |
| OTHER | Glucose tolerance test | |
| OTHER | Echocardiography | |
| OTHER | cardiac and abdominal magnetic resonance imaging | |
| OTHER | Ambulatory blood pressure monitoring | |
| OTHER | Echotracking | |
| OTHER | Pulse wave velocity | |
| OTHER | Composition of body mass by Dual x-ray absorptiometry |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-10-30
- Last updated
- 2015-08-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01716819. Inclusion in this directory is not an endorsement.